Immediate Impact
21 standout
Citing Papers
Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review
2025 Standout
Understanding the therapeutic toolkit for inflammatory bowel disease
2025 Standout
Works of Jacek Romatowski being referenced
Anti-TL1A Antibody PF-06480605 Safety and Efficacy for Ulcerative Colitis: A Phase 2a Single-Arm Study
2021
Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jacek Romatowski | 93 | 57 | 54 | 16 | 191 | |
| J Emmrich | 72 | 43 | 64 | 22 | 250 | |
| Federico Zanzi | 82 | 58 | 40 | 15 | 138 | |
| Cristina Nichita | 107 | 99 | 25 | 13 | 196 | |
| Catherine Dong | 129 | 104 | 86 | 12 | 218 | |
| Masanori Tanaka | 93 | 73 | 68 | 15 | 240 | |
| Shaohong Yang | 70 | 43 | 26 | 15 | 166 | |
| Zhihua Ran | 138 | 94 | 66 | 25 | 265 | |
| Anneline Cremer | 157 | 125 | 71 | 20 | 210 | |
| Dolóresz Szabó | 79 | 53 | 29 | 18 | 191 | |
| Massimo Devani | 74 | 49 | 87 | 21 | 261 |
All Works
Loading papers...